PLASMA CELL LEUKEMIA
Clinical trials for PLASMA CELL LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new PLASMA CELL LEUKEMIA trials appear
Sign up with your email to follow new studies for PLASMA CELL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Double CAR-T attack on rare blood cancer shows promise
Disease control Recruiting nowThis study is testing a combination treatment for newly diagnosed primary plasma cell leukemia, a rare and aggressive blood cancer. Patients receive chemotherapy, two rounds of CAR-T cell therapy (which uses modified immune cells to target cancer), and a stem cell transplant. The…
Matched conditions: PLASMA CELL LEUKEMIA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New 'Go-Slow' strategy aims to help frailest cancer patients tolerate treatment
Disease control Recruiting nowThis study is testing a gentler way to start treatment for very frail older adults with multiple myeloma, a blood cancer. Researchers want to see if beginning with two drugs and slowly adding a third helps patients complete their treatment and feel better. The goal is to improve …
Matched conditions: PLASMA CELL LEUKEMIA
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Radical transplant trial aims to replace diseased blood systems
Disease control Recruiting nowThis study is testing a specific type of stem cell transplant using donated umbilical cord blood to treat patients with serious blood cancers and disorders. The procedure involves high-dose chemotherapy and radiation to wipe out the patient's diseased bone marrow before infusing …
Matched conditions: PLASMA CELL LEUKEMIA
Phase: NA • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Supercharged cord blood cells target tough blood cancers
Disease control Recruiting nowThis study is testing a new cell therapy for patients whose blood cancers have returned or not responded to standard treatments. Researchers are giving patients specially engineered immune cells, called NK cells, which come from donated cord blood. The goal is to see if these mod…
Matched conditions: PLASMA CELL LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Last-Hope drug offered early to blood cancer patients
Disease control AVAILABLEThis program provides early access to the drug venetoclax for patients with certain blood cancers like leukemia and lymphoma before it is fully approved in their country. It is for patients who have no other suitable treatment options and do not qualify for ongoing clinical trial…
Matched conditions: PLASMA CELL LEUKEMIA
Sponsor: AbbVie • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC
-
Massive biobank project seeks 6,000 patients to donate samples for future research
Knowledge-focused Recruiting nowThis study aims to collect and store blood and tissue samples from patients with multiple myeloma and related conditions. Researchers will gather samples and health information from 6,000 participants across multiple countries to create a large biobank for future research. The go…
Matched conditions: PLASMA CELL LEUKEMIA
Sponsor: European Myeloma Network B.V. • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:41 UTC
-
Major registry launches to study aging and blood cancers
Knowledge-focused Recruiting nowThis study is creating a large registry to track the health of older adults (age 50+) with blood cancers like multiple myeloma. Researchers will collect information through questionnaires and simple physical tests to understand how frailty and aging affect these patients. The goa…
Matched conditions: PLASMA CELL LEUKEMIA
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC
-
Major cancer center launches massive registry to track rare blood disorders
Knowledge-focused Recruiting nowThis study is creating a large registry of 2000 adults with plasma cell disorders like multiple myeloma and amyloidosis. Participants complete health assessments about their daily function, medical conditions, and quality of life over time, and can optionally give blood samples f…
Matched conditions: PLASMA CELL LEUKEMIA
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:20 UTC